Both in Biotechnology
Champions Oncology vs MiNK Therapeutics
Over the past year CSBR returned −29.0% and INKT returned −19.8%; their daily moves had a correlation of -0.00.
CSBR −29.0% INKT −19.8%Growth of $1, one year, split-adjusted
| Metric | CSBR | INKT |
|---|---|---|
| Price | $4.83 | $10.79 |
| Market cap | $67.2M | $55.1M |
| Today | +0.42% | −2.26% |
| 1 month | −2.8% | −11.6% |
| 6 months | −19.1% | −6.5% |
| Year to date | −30.1% | −3.2% |
| 1 year | — | −23.1% |
| Revenue growth (YoY) | +8.8% | — |
| Gross margin | 50.5% | — |
| Net margin | −2.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 1.1× | — |
| Net cash | $4.4M | $8.8M |
| Dividend yield | — | — |
| Volatility (60d) | 35.4% | 51.1% |
| Short % of float | 1.5% | 2.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).